Skip to content

Randomised trial, 2002

How well does magnesium supplementation reduce premenstrual symptoms?

Unexpectedly, the placebo (sorbitol) worked better than magnesium at any dose. Sorbitol reduced anxiety-related and total symptoms more than all three magnesium doses, suggesting sorbitol itself has an effect specific to women with PMS.

Moderate study design 85 women with premenstrual symptoms

What they did

85 women with premenstrual symptoms took one of four daily treatments in random order: magnesium at 200, 350, or 500 mg, or sorbitol placebo at 1305 mg. Each treatment lasted 2 months, with a 1-month break between treatments in a double-blind crossover study.

What they found

Sorbitol unexpectedly reduced anxiety-related and total premenstrual symptoms more than all three magnesium doses after 2 months (P<0.001 for both). Sorbitol also reduced urinary magnesium excretion compared to baseline and magnesium treatments (P=0.005). When 17 healthy volunteers received sorbitol, it had no effect on urinary magnesium or mood.

What it means for you

This surprising finding shows that placebo is not always inert. Sorbitol appears to affect how the body handles magnesium specifically in women with PMS, not in healthy women. This challenges assumptions about placebos in research and raises questions about how to choose them.

85 women

sample size

1305 mg

sorbitol dose

2 months

per treatment

About the study

Original title
Unexpected benefit of sorbitol placebo in Mg intervention study of premenstrual symptoms: implications for choice of placebo in RCTs
Authors
Walker AF, De Souza MC, Marakis G et al.
Journal
Medical hypotheses
Year
2002
Study design
Randomised trial
Participants
85
What was tested
Magnesium (200, 350, or 500 mg daily) or sorbitol placebo (1305 mg daily)

Topics